Pontocerebellar hypoplasia type 1: Clinical spectrum and relevance of EXOSC3 mutations

Sabine Rudnik-Schöneborn, Jan Senderek, Joanna C. Jen, Gunnar Houge, Pavel Seeman, Alena Puchmajerová, Luitgard Graul-Neumann, Ulrich Seidel, Rudolf Korinthenberg, Janbernd Kirschner, Jürgen Seeger, Monique M. Ryan, Francesco Muntoni, Maja Steinlin, Laszlo Sztriha, Jaume Colomer, Christoph Hübner, Knut Brockmann, Lionel Van Maldergem, Manuel SchiffAndreas Holzinger, Peter Barth, William Reardon, Michael Yourshaw, Stanley F. Nelson, Thomas Eggermann, Klaus Zerres

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Objectives: Pontocerebellar hypoplasia with spinal muscular atrophy, also known as PCH1, is a group of autosomal recessive disorders characterized by generalized muscle weakness and global developmental delay commonly resulting in early death. Gene defects had been discovered only in single patients until the recent identification of EXOSC3 mutations in several families with relatively mild course of PCH1.We aim to genetically stratify subjects in a large and well-defined cohort to define the clinical spectrum and genotypephenotype correlation. Methods: We documented clinical, neuroimaging, and morphologic data of 37 subjects from 27 families with PCH1. EXOSC3 gene sequencing was performed in 27 unrelated index patients of mixed ethnicity. Results: Biallelic mutations in EXOSC3 were detected in 10 of 27 families (37%). The most common mutation among all ethnic groups was c.395A>C, p.D132A, responsible for 11 (55%) of the 20 mutated alleles and ancestral in origin. The mutation-positive subjects typically presented with normal pregnancy, normal birth measurements, and relative preservation of brainstemand cortical structures. Psychomotor retardation was profound in all patients but lifespan was variable, with 3 subjects surviving beyond the late teens. Abnormal oculomotor function was commonly observed in patients surviving beyond the first year. Major clinical features previously reported in PCH1, including intrauterine abnormalities, postnatal hypoventilation and feeding difficulties, joint contractures, and neonatal death,were rarely observed inmutation-positive infants but were typical among themutation-negative subjects. Conclusion: EXOSC3 mutations account for 30%-40% of patients with PCH1 with variability in survival and clinical severity that is correlated with the genotype.

Original languageEnglish
Pages (from-to)438-446
Number of pages9
JournalNeurology
Volume80
Issue number5
DOIs
Publication statusPublished - Jan 29 2013

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Pontocerebellar hypoplasia type 1: Clinical spectrum and relevance of EXOSC3 mutations'. Together they form a unique fingerprint.

  • Cite this

    Rudnik-Schöneborn, S., Senderek, J., Jen, J. C., Houge, G., Seeman, P., Puchmajerová, A., Graul-Neumann, L., Seidel, U., Korinthenberg, R., Kirschner, J., Seeger, J., Ryan, M. M., Muntoni, F., Steinlin, M., Sztriha, L., Colomer, J., Hübner, C., Brockmann, K., Van Maldergem, L., ... Zerres, K. (2013). Pontocerebellar hypoplasia type 1: Clinical spectrum and relevance of EXOSC3 mutations. Neurology, 80(5), 438-446. https://doi.org/10.1212/WNL.0b013e31827f0f66